Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.05
+0.12 (0.80%)
Apr 13, 2026, 2:30 PM EDT - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $915.52 million as of April 13, 2026. Its market cap has decreased by -48.57% in one year.
Market Cap
915.52M
Enterprise Value
-34.39M
1-Year Change
-48.57%
Ranking
Category
Stock Price
$15.05
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $915.52M, an increase of 49.17%. That is a compound annual growth rate of 8.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 908.22M | 9.42% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 961.70M |
| CytomX Therapeutics | 949.02M |
| Annexon | 938.77M |
| Aktis Oncology | 933.06M |
| Compass Therapeutics | 931.05M |
| Evommune | 918.83M |
| Xencor | 910.87M |
| Jade Biosciences | 882.27M |